HUMAN GENE MARKER/THERAPY CLINICAL PROTOCOLS (Complete Updated Listings)
1999; Mary Ann Liebert, Inc.; Volume: 10; Issue: 6 Linguagem: Inglês
10.1089/10430349950018445
ISSN1557-7422
Tópico(s)BRCA gene mutations in cancer
ResumoHuman Gene TherapyVol. 10, No. 6 HUMAN GENE MARKER/THERAPY CLINICAL PROTOCOLS (Complete Updated Listings)Published Online:6 Jul 2004https://doi.org/10.1089/10430349950018445AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byEnhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDCGynecologic Oncology, Vol. 90, No. 2GENE THERAPYNursing Clinics of North America, Vol. 35, No. 3Using a Tropism-Modified Adenoviral Vector to Circumvent Inhibitory Factors in Ascites Fluid Jerry L. Blackwell, Hui Li, Jesus Gomez-Navarro, Igor Dmitriev, Victor Krasnykh, Christy A. Richter, Denise R. Shaw, Ronald D. Alvarez, David T. Curiel, and Theresa V. Strong6 July 2004 | Human Gene Therapy, Vol. 11, No. 12Potential Applications of Gene Therapy in the Patient with CancerDrugs & Aging, Vol. 17, No. 2The potential of gene therapy in the treatment of hepatocellular carcinomaJournal of Hepatology, Vol. 32, No. 2 Volume 10Issue 6Apr 1999 To cite this article:HUMAN GENE MARKER/THERAPY CLINICAL PROTOCOLS (Complete Updated Listings).Human Gene Therapy.Apr 1999.1043-1092.http://doi.org/10.1089/10430349950018445Published in Volume: 10 Issue 6: July 6, 2004PDF download
Referência(s)